Advertisement
Screener

Celularity Inc. (CELU) Return on Tangible Equity

2.8 / 5 stars · 68/120 Roast Me

Celularity Inc Return Tang Equity

Return on tangible equity is the profit a company earns on the physical and financial capital its shareholders own, leaving out goodwill and other intangible assets, shown as a percentage. It is net income divided by tangible equity, which is shareholder equity minus goodwill and intangibles; the table shows both amounts. Because acquired goodwill is removed, it runs higher than ROE for companies that grew by acquisition, and it has no meaning when goodwill exceeds equity. Goodwill and intangibles are taken at the latest reported date on or before each equity date. Quarterly points divide the trailing four quarters of net income by the balance at that quarter end; annual points divide the filed fiscal-year net income by the fiscal-year-end balance.

  • Celularity Inc return tang equity for the quarter ending 2025-12-31 was 174.81%, a 78.69% decline year-over-year.
  • Celularity Inc return tang equity for the quarter ending 2025-09-30 was 231.26%, a change of 3705.19% year-over-year.
  • Celularity Inc return tang equity for the quarter ending 2025-06-30 was 181.22%, a change of 1191.79% year-over-year.
  • Celularity Inc return tang equity for the quarter ending 2025-03-31 was 264.50%, a change of 1355.44% year-over-year.
  • Celularity Inc return tang equity for fiscal 2025 was 174.81%, a 78.69% decline from fiscal 2024.
  • Celularity Inc return tang equity for fiscal 2024 was 820.23%, a change of 1662.27% from fiscal 2023.
  • Celularity Inc return tang equity for fiscal 2023 was -842.03%, a 4058.19% decline from fiscal 2022.
  • Celularity Inc return tang equity for fiscal 2022 was 21.27%, a 91.80% decline from fiscal 2021.
Available history
2019-12-31 to 2025-12-31
Data captured

Historical Return Tang Equity

DateReturn Tang EquityNet income 12 monthTangible equity
2025-12-31174.81%-$91.72M-$52.47M
2025-09-30231.26%-$80.65M-$34.87M
2025-06-30181.22%-$73.67M-$40.65M
2025-03-31264.50%-$55.63M-$21.03M
2024-12-31820.23%-$57.89M-$7.06M
2024-09-30-3473.93%-$35.05M$1.01M
2024-06-30-1010.57%-$112.83M$11.17M
2024-03-31-1090.94%-$154.29M$14.14M
2023-12-31-842.03%-$196.3M$23.31M
2023-09-30-1505.96%-$181.41M$12.05M
2023-06-30-485.72%-$82.73M$17.03M
2023-03-3124.33%$13.04M$53.61M
2022-12-3121.27%$14.19M$66.71M
2022-09-30-51.22%-$14.28M$27.88M
2022-06-30232.95%$30.86M$13.25M
2022-03-31171.30%-$81.45M-$47.55M
2021-12-31259.55%-$100.12M-$38.57M
2021-09-30217.75%-$92.17M-$42.33M
2021-06-3023.90%-$188.43M-$788.39M
2021-03-3118.09%-$136.06M-$752.11M
2020-12-317.17%-$48.16M-$671.58M
2020-09-307.23%-$47.94M-$663.48M
2020-06-300.08%-$497,170.00-$618.02M
2020-03-31-2.53%$12.25M-$483.85M
2019-12-31-1.29%$5.88M-$454.49M

Annual Return Tang Equity

DateReturn Tang EquityNet income 12 monthTangible equity
2025-12-31174.81%-$91.72M-$52.47M
2024-12-31820.23%-$57.89M-$7.06M
2023-12-31-842.03%-$196.3M$23.31M
2022-12-3121.27%$14.19M$66.71M
2021-12-31259.55%-$100.12M-$38.57M
2020-12-3131.01%-$208.23M-$671.58M
2019-12-31-1.29%$5.88M-$454.49M

Similar stocks

Stock NameCountryMarket CapPE Ratio
CervoMed Inc. (CRVO)United States$0.038B-1.39
Actinium Pharmaceuticals, Inc. (ATNM)United States$0.038B2.73
FILANA THERAPEUTICS, INC. (FLNA)United States$0.038B-1.05
PMGC Holdings Inc. (ELAB)United States$0.037B
Edesa Biotech, Inc. (EDSA)Canada$0.039B
BriaCell Therapeutics Corp. (BCTX)$0.037B
Karyopharm Therapeutics Inc. (KPTI)United States$0.039B-0.98
Seres Therapeutics, Inc. (MCRB)United States$0.036B-3.45
MIRA PHARMACEUTICALS, INC. (MIRA)United States$0.036B-4.30
Incannex Healthcare Inc. (IXHL)$0.040B-22.32